[HTML][HTML] Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma
JL Marks, S Broderick, Q Zhou, D Chitale, AR Li… - Journal of thoracic …, 2008 - Elsevier
Background Somatic mutations in EGFR (exons 19 and 21) and KRAS (exon 2) are found in
lung adenocarcinomas and have potential prognostic value in patients with advanced …
lung adenocarcinomas and have potential prognostic value in patients with advanced …
[PDF][PDF] Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma
JL Marks, S Broderick, Q Zhou, D Chitale… - Journal of Thoracic …, 2008 - core.ac.uk
Background: Somatic mutations in EGFR (exons 19 and 21) and KRAS (exon 2) are found in
lung adenocarcinomas and have potential prognostic value in patients with advanced …
lung adenocarcinomas and have potential prognostic value in patients with advanced …
Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma.
JL Marks, S Broderick, Q Zhou, D Chitale… - Journal of Thoracic …, 2008 - europepmc.org
Background Somatic mutations in EGFR (exons 19 and 21) and KRAS (exon 2) are found in
lung adenocarcinomas and have potential prognostic value in patients with advanced …
lung adenocarcinomas and have potential prognostic value in patients with advanced …
Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma
JL Marks, S Broderick, Q Zhou… - Journal of Thoracic …, 2008 - pure.johnshopkins.edu
BACKGROUND: Somatic mutations in EGFR (exons 19 and 21) and KRAS (exon 2) are
found in lung adenocarcinomas and have potential prognostic value in patients with …
found in lung adenocarcinomas and have potential prognostic value in patients with …
[引用][C] Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma
JL Marks, S Broderick, Q Zhou, D Chitale… - Journal of Thoracic …, 2008 - cir.nii.ac.jp
Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung
Adenocarcinoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
Adenocarcinoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
[PDF][PDF] Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma
JL Marks, S Broderick, Q Zhou, D Chitale… - Journal of Thoracic …, 2008 - scholar.archive.org
Background: Somatic mutations in EGFR (exons 19 and 21) and KRAS (exon 2) are found in
lung adenocarcinomas and have potential prognostic value in patients with advanced …
lung adenocarcinomas and have potential prognostic value in patients with advanced …
Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma
JL Marks, S Broderick, Q Zhou… - Journal of thoracic …, 2008 - pubmed.ncbi.nlm.nih.gov
Background Somatic mutations in EGFR (exons 19 and 21) and KRAS (exon 2) are found in
lung adenocarcinomas and have potential prognostic value in patients with advanced …
lung adenocarcinomas and have potential prognostic value in patients with advanced …
[HTML][HTML] Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma
JL Marks, S Broderick, Q Zhou, D Chitale, AR Li… - Journal of Thoracic …, 2008 - jto.org
Background Somatic mutations in EGFR (exons 19 and 21) and KRAS (exon 2) are found in
lung adenocarcinomas and have potential prognostic value in patients with advanced …
lung adenocarcinomas and have potential prognostic value in patients with advanced …
[引用][C] Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma
M JL - J Thorac Oncol, 2008 - cir.nii.ac.jp
Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung
adenocarcinoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
adenocarcinoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …